Correlation Between PhaseBio Pharmaceuticals and Covalon Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PhaseBio Pharmaceuticals and Covalon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PhaseBio Pharmaceuticals and Covalon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PhaseBio Pharmaceuticals and Covalon Technologies, you can compare the effects of market volatilities on PhaseBio Pharmaceuticals and Covalon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PhaseBio Pharmaceuticals with a short position of Covalon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of PhaseBio Pharmaceuticals and Covalon Technologies.

Diversification Opportunities for PhaseBio Pharmaceuticals and Covalon Technologies

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between PhaseBio and Covalon is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding PhaseBio Pharmaceuticals and Covalon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Covalon Technologies and PhaseBio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PhaseBio Pharmaceuticals are associated (or correlated) with Covalon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Covalon Technologies has no effect on the direction of PhaseBio Pharmaceuticals i.e., PhaseBio Pharmaceuticals and Covalon Technologies go up and down completely randomly.

Pair Corralation between PhaseBio Pharmaceuticals and Covalon Technologies

If you would invest  92.00  in Covalon Technologies on September 2, 2024 and sell it today you would earn a total of  170.00  from holding Covalon Technologies or generate 184.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

PhaseBio Pharmaceuticals  vs.  Covalon Technologies

 Performance 
       Timeline  
PhaseBio Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PhaseBio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PhaseBio Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Covalon Technologies 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Covalon Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Covalon Technologies reported solid returns over the last few months and may actually be approaching a breakup point.

PhaseBio Pharmaceuticals and Covalon Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PhaseBio Pharmaceuticals and Covalon Technologies

The main advantage of trading using opposite PhaseBio Pharmaceuticals and Covalon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PhaseBio Pharmaceuticals position performs unexpectedly, Covalon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will offset losses from the drop in Covalon Technologies' long position.
The idea behind PhaseBio Pharmaceuticals and Covalon Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities